Wobus A M, Schöneich J, Thieme R
Mutat Res. 1978 Sep;58(1):67-77. doi: 10.1016/0165-1218(78)90096-4.
The cytogenetic effects of intraperitoneally (i.p.) and subcutaneously (s.c.) administered nitrogen mustard (HN2) and cytosine arabinoside (ara-C) on bone-marrow and ascites tumour cells of mice were studied. Ehrlich ascites tumour-bearing mice were treated with the mutagens, and cytological preparations were made from ascites tumour and bone-marrow cells of the same animal. The following parameters were investigated: frequencies of mitotic and chromosomal aberrations, time of aberration maxima and aberration spectra. HN2 (0.68 mg/kg b.w.), when given i.p., induced in ascites tumour cells a strong inhibition of mitotic frequency and very high aberration rates, whereas in bone marrow no aberrant chromosomes were observed. On the other hand, after s.c. administration, the same dose induced more aberrant metaphases in bone marrow than in tumour cells. Ara-C (315 mg/kg b.w.) resulted, after s.c. administration, in higher aberration frequencies both in ascites and bone-marrow cells compared with i.p. treatment. All ascites tumour cells showed higher aberration requencies than bone-marrow cells. In bone marrow the aberration maximum occurred as soon as 6 h after treatment. Furthermore, clear differences with respect ot the types of aberration found in the two systems were evident. The differences caused by the different modes of administration in two different types of cell are discussed in terms of metabolic inactivation and differences of the two tissues with respect to karyotype, cell cycle time and repair capacity.
研究了腹腔内(i.p.)和皮下(s.c.)注射氮芥(HN2)和阿糖胞苷(ara-C)对小鼠骨髓和腹水肿瘤细胞的细胞遗传学效应。用诱变剂处理荷艾氏腹水瘤小鼠,并从同一只动物的腹水肿瘤细胞和骨髓细胞制备细胞学标本。研究了以下参数:有丝分裂和染色体畸变频率、畸变最大值出现时间和畸变谱。腹腔注射0.68 mg/kg体重的HN2可使腹水肿瘤细胞的有丝分裂频率受到强烈抑制,畸变率极高,而在骨髓中未观察到异常染色体。另一方面,皮下注射相同剂量后,骨髓中出现的异常中期比肿瘤细胞中更多。皮下注射阿糖胞苷(315 mg/kg体重)后,与腹腔注射相比,腹水和骨髓细胞中的畸变频率更高。所有腹水肿瘤细胞的畸变频率均高于骨髓细胞。在骨髓中,处理后6小时即出现畸变最大值。此外,两个系统中发现的畸变类型存在明显差异。从代谢失活以及两种组织在核型、细胞周期时间和修复能力方面的差异,讨论了两种不同给药方式在两种不同类型细胞中所造成的差异。